Biocon board approves sale of branded formulations business to subsidiary

The Board of Directors in its meeting approved the sale of Branded Formulations India (BFI) business to Biocon Biologics India (BBIL).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news